A Phase I Trial of Tailored Radiation Therapy With Concomitant Cetuximab (C225, NSC 714692) and Cisplatin (NSC 119875) in the Treatment of Patients With Cervical Cancer.

Trial Profile

A Phase I Trial of Tailored Radiation Therapy With Concomitant Cetuximab (C225, NSC 714692) and Cisplatin (NSC 119875) in the Treatment of Patients With Cervical Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jan 2015

At a glance

  • Drugs Cetuximab; Cisplatin
  • Indications Cervical cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Jul 2012 Planned end date changed from 1 Jul 2008 to 1 Jan 2013 as reported by ClinicalTrials.gov.
    • 18 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 04 Apr 2008 Trial centre (Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center) added according to ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top